Assembly Biosciences (ASMB) Accounts Payables (2010 - 2026)

Assembly Biosciences' Accounts Payables history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 29.03% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 29.03% YoY), while the FY2025 annual figure was $1.2 million, up 100.17% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.1 million, down from $1.2 million in the prior quarter.
• The five-year high for Accounts Payables was $2.5 million in Q4 2022, with the low at $461000.0 in Q4 2023.
• The 5-year median for Accounts Payables is $1.1 million (2026), against an average of $1.2 million.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 81.51% in 2023, then soared 100.17% in 2025.
• Assembly Biosciences' Accounts Payables stood at $2.5 million in 2022, then plunged by 81.51% to $461000.0 in 2023, then advanced by 26.9% to $585000.0 in 2024, then jumped by 100.17% to $1.2 million in 2025, then fell by 3.59% to $1.1 million in 2026.
• Business Quant data shows ASMB's Accounts Payables at $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $1.7 million in Q3 2025.